EPS for Medidata Solutions, Inc. (MDSO) Expected At $0.18

January 8, 2018 - By Maria Brooks

 EPS for Medidata Solutions, Inc. (MDSO) Expected At $0.18
Investors sentiment increased to 1.23 in Q3 2017. Its up 0.06, from 1.17 in 2017Q2. It improved, as 38 investors sold Medidata Solutions, Inc. shares while 60 reduced holdings. 33 funds opened positions while 88 raised stakes. 59.30 million shares or 4.96% more from 56.50 million shares in 2017Q2 were reported.
Advantus Capital Mgmt reported 0.01% stake. Los Angeles & Equity Inc has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). Moreover, Alliancebernstein Limited Partnership has 0.01% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 88,457 shares. Kames Public Ltd Com owns 16,509 shares for 0.04% of their portfolio. Michigan-based Ls Ltd Liability has invested 0.03% in Medidata Solutions, Inc. (NASDAQ:MDSO). Dimensional Fund Limited Partnership has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). New York State Common Retirement Fund has invested 0.1% in Medidata Solutions, Inc. (NASDAQ:MDSO). 182,210 are held by Metropolitan Life Insur. Bnp Paribas Arbitrage holds 26,361 shares or 0.01% of its portfolio. Moreover, Hartwell J M Partnership has 0.11% invested in Medidata Solutions, Inc. (NASDAQ:MDSO). Prelude Capital Mngmt Ltd Co holds 2,403 shares or 0.02% of its portfolio. Paloma Partners Mngmt has invested 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Columbia Wanger Asset Management Ltd Liability stated it has 455,446 shares. Oregon Employees Retirement Fund invested 0.03% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Blackrock Inc has 0.03% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 6.60M shares.

Since August 15, 2017, it had 0 insider buys, and 2 selling transactions for $504,550 activity. Capone Michael L had sold 5,000 shares worth $372,650 on Tuesday, August 15.

Analysts expect Medidata Solutions, Inc. (NASDAQ:MDSO) to report $0.18 EPS on February, 8.They anticipate $0.05 EPS change or 21.74 % from last quarter’s $0.23 EPS. MDSO’s profit would be $10.53 million giving it 90.10 P/E if the $0.18 EPS is correct. After having $0.22 EPS previously, Medidata Solutions, Inc.’s analysts see -18.18 % EPS growth. The stock increased 0.12% or $0.08 during the last trading session, reaching $64.87. About 382,858 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 68.37% since January 8, 2017 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. had 38 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Deutsche Bank with “Buy” on Tuesday, September 13. The firm has “Hold” rating given on Friday, September 25 by Topeka Capital Markets. As per Thursday, February 11, the company rating was maintained by Topeka Capital Markets. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Buy” rating given on Monday, October 23 by Needham. As per Wednesday, June 14, the company rating was maintained by Morgan Stanley. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Deutsche Bank on Friday, December 8. The stock has “Buy” rating by Topeka Capital Markets on Wednesday, October 28. The rating was downgraded by Wells Fargo to “Market Perform” on Thursday, July 21. The company was upgraded on Monday, November 13 by Dougherty. The rating was maintained by Jefferies with “Hold” on Friday, June 16.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $3.79 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 92.8 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More news for Medidata Solutions, Inc. (NASDAQ:MDSO) were recently published by: Seekingalpha.com, which released: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q3 2017 Results – Earnings Call …” on October 26, 2017. Seekingalpha.com‘s article titled: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q2 2017 Results – Earnings Call …” and published on July 18, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: